Table 1.
Overall Demographics and Surgical Characteristics of Patients Undergoing Immediate Breast Reconstruction after Mastectomy Assessed with the Mastectomy Flap Ischemia Risk Score
No. (Patients) | 31 |
---|---|
No. (breasts) | 45 |
Age, y | 47.71 |
Body mass index, kg/m2 | 27.77 |
Mastectomy indication | Therapeutic: 28 (62.2%); prophylactic: 17 (37.8%) |
Smoking history | Active: 2 (4.4%); former: 3 (6.7%) |
Prior radiation | 6 (13.3%) |
Prior chemotherapy | 18 (40.0%) |
Lymph node biopsy or dissection performed | 26 (57.8%) |
Adjuvant radiation | 7 (15.6%) |
Adjuvant chemotherapy | 6 (13.3%) |
Pathologic breast cancer stage | 0: 21 (46.7%) |
IA: 11 (24.4%) | |
IB: 2 (4.4%) | |
IIA: 5 (11.1%) | |
IIB: 3 (6.7%) | |
IIIA: 2 (4.4%) | |
IIIC: 1 (2.2%) | |
Mastectomy type | Skin-sparing mastectomy: 42 (93.3%) Nipple-sparing mastectomy: 3 (6.7%) |
Mastectomy incision | Ellipse: 42 (93.3%) Inframammary fold: 3 (6.7%) |
Sternal notch–nipple distance, cm | 22.93 (36) |
Nipple–inframammary fold distance, cm | 9.36 (36) |
Breast width, cm | 14.09 (41) |
Incision–clavicle distance, cm | 15.04 (43) |
Incision–inframammary fold distance, cm | 6.39 (43) |
Reconstructive modality | Tissue expander: 29 (64.4%) Autologous: 16 (35.6%) |
Acellular dermal matrix | 20 (69.0%) |
Follow-up, mo | 11.16 |